• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Mortality due to C difficile colitis in elderly people has been underestimated.

作者信息

Lesna M, Parham D M

出版信息

BMJ. 1996 Mar 23;312(7033):778. doi: 10.1136/bmj.312.7033.778a.

DOI:10.1136/bmj.312.7033.778a
PMID:8605487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2350454/
Abstract
摘要

相似文献

1
Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Mortality due to C difficile colitis in elderly people has been underestimated.头孢噻肟治疗期间艰难梭菌所致腹泻的风险。老年人艰难梭菌结肠炎所致死亡率一直被低估。
BMJ. 1996 Mar 23;312(7033):778. doi: 10.1136/bmj.312.7033.778a.
2
Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Cefotaxime compares favourably with other third generation cephalosporins.头孢噻肟治疗期间艰难梭菌所致腹泻的风险。头孢噻肟与其他第三代头孢菌素相比具有优势。
BMJ. 1996 Mar 23;312(7033):778. doi: 10.1136/bmj.312.7033.778.
3
Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly.
Biomed Pharmacother. 1997;51(2):63-7. doi: 10.1016/s0753-3322(97)87728-1.
4
Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.接受头孢噻肟治疗的老年患者感染艰难梭菌导致腹泻的风险增加。
BMJ. 1995 Nov 18;311(7016):1345-6. doi: 10.1136/bmj.311.7016.1345.
5
Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam.
Aliment Pharmacol Ther. 1998 Dec;12(12):1217-23. doi: 10.1046/j.1365-2036.1998.00428.x.
6
[The Norrköping study. Cephalosporins are often the implicating factors in Clostridium difficile infections].[诺尔雪平研究。头孢菌素常常是艰难梭菌感染的诱发因素]
Lakartidningen. 1991 Oct 9;88(41):3374, 3377, 3379.
7
Effectiveness of antibiotic prophylaxis in critically ill patients. Antibiotic prophylaxis can lead to contamination with Clostridium difficile.危重症患者抗生素预防的有效性。抗生素预防可导致艰难梭菌感染。
BMJ. 1998 Nov 28;317(7171):1527.
8
Hospital-acquired Clostridium difficile diarrhoea and herd immunity.
Lancet. 1997 Feb 8;349(9049):426-8. doi: 10.1016/S0140-6736(97)80053-0.
9
[Cephalosporins--a common cause of nosocomial Clostridium difficile diarrhea].[头孢菌素——医院获得性艰难梭菌腹泻的常见病因]
Lakartidningen. 1992 Jan 15;89(3):109-10.
10
Association of IgA nephropathy with Clostridium difficile colitis.IgA肾病与艰难梭菌结肠炎的关联。
Am J Kidney Dis. 1999 Oct;34(4):e16. doi: 10.1053/AJKD034000e16.

引用本文的文献

1
Mortality in hospitalized older adults associated with Clostridium difficile infection at a district hospital.一家区级医院中住院老年患者艰难梭菌感染相关的死亡率
Infect Dis Rep. 2010 Jun 21;2(1):e8. doi: 10.4081/idr.2010.e8. eCollection 2010 Feb 3.
2
Severe acute diarrhea.严重急性腹泻
Gastroenterol Clin North Am. 2003 Dec;32(4):1249-67. doi: 10.1016/s0889-8553(03)00100-6.
3
Mechanisms of drug-induced diarrhoea in the elderly.老年人药物性腹泻的机制
Drugs Aging. 1998 Sep;13(3):245-53. doi: 10.2165/00002512-199813030-00007.
4
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.头孢噻肟。对其抗菌活性和药代动力学特性的重新评估，以及对其每日两次给药治疗轻至中度感染时的治疗效果的综述。
Drugs. 1997 Mar;53(3):483-510. doi: 10.2165/00003495-199753030-00009.

本文引用的文献

1
Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.接受头孢噻肟治疗的老年患者感染艰难梭菌导致腹泻的风险增加。
BMJ. 1995 Nov 18;311(7016):1345-6. doi: 10.1136/bmj.311.7016.1345.